Nuvectis Pharma, Inc. (27)
Browse by Contract Category
Contracts
-
Form of Registration Rights Agreement by and among Nuvectis Pharma, Inc. and the Purchasers, dated July 27, 2022
(Filed With SEC on July 29, 2022)
-
Form of Preferred Investment Option
(Filed With SEC on July 29, 2022)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on October 28, 2021)
-
License Agreement between Nuvectis Pharma, Inc. and The University Court of the University of Edinburgh, dated August 26, 2021
(Filed With SEC on October 21, 2021)
-
Form of Pre-Funded Stock Purchase Warrant
(Filed With SEC on July 29, 2022)
-
Form of Securities Purchase Agreement by and among Nuvectis Pharma, Inc. and the Purchasers, dated July 27, 2022
(Filed With SEC on July 29, 2022)
-
Description of Securities of Nuvectis Pharma, Inc
(Filed With SEC on March 23, 2022)
-
Underwriting Agreement, dated February 4, 2022, between Nuvectis Pharma, Inc. and H.C. Wainwright & Co., LLC, as representative of the several underwriters named therein
(Filed With SEC on February 4, 2022)
-
Form of Warrant
(Filed With SEC on January 18, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on January 18, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on October 28, 2021)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on October 28, 2021)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on October 28, 2021)
-
Form of Warrant
(Filed With SEC on October 28, 2021)
-
License Agreement between Nuvectis Pharma, Inc. and CRT Pioneer Fund LP dated May 19, 2021
(Filed With SEC on October 21, 2021)
-
Executive Employment Agreement with Uri Ben-Or, dated March 29, 2021
(Filed With SEC on October 21, 2021)
-
Form of Executive Employment Agreement with Shay Shemesh
(Filed With SEC on October 21, 2021)
-
Form of Executive Employment Agreement with Enrique Poradosu
(Filed With SEC on October 21, 2021)
-
Form of Executive Employment Agreement with Ron Bentsur
(Filed With SEC on October 21, 2021)
-
Form of Common Stock Certificate
(Filed With SEC on October 21, 2021)
-
Global Equity Incentive Plan
(Filed With SEC on October 6, 2021)
-
License Agreement between Nuvectis Pharma, Inc. and The University Court of the University of Edinburgh, dated August 26, 2021
(Filed With SEC on October 6, 2021)
-
License Agreement between Nuvectis Pharma, Inc. and CRT Pioneer Fund LP dated May 19, 2021
(Filed With SEC on October 6, 2021)
-
Form of Executive Employment Agreement with Shay Shemesh
(Filed With SEC on October 6, 2021)
-
Form of Executive Employment Agreement with Enrique Poradosu
(Filed With SEC on October 6, 2021)
-
Form of Executive Employment Agreement with Ron Bentsur
(Filed With SEC on October 6, 2021)
-
Form of Common Stock Certificate
(Filed With SEC on October 6, 2021)
